Kimberly Manhard, Director at Inhibrx Biosciences, Inc. (INBX), sold 1,500 shares at $111.78 ($164K) on 2026-09-11, disclosed to the SEC on 2026-09-15.
Open-market sale of $164k INBX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $111.78 | 500 | $56K | 34.2% |
| 2 | $110.26 | 500 | $55K | 33.7% |
| 3 | $105.05 | 500 | $53K | 32.1% |
| Total | $109.03 avg | 1,500 | $164K | 100% |
| Filing → |
| HRTX | SELL | 2022-05-04 | $7K | — | Filing → |
| HRTX | SELL | 2021-05-04 | $27K | — | Filing → |
| HRTX | SELL | 2020-12-23 | $200K | — | Filing → |